These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10742298)

  • 21. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage.
    Fiorucci S; de Lima OM; Mencarelli A; Palazzetti B; Distrutti E; McKnight W; Dicay M; Ma L; Romano M; Morelli A; Wallace JL
    Gastroenterology; 2002 Nov; 123(5):1598-606. PubMed ID: 12404234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors.
    White WB; Kent J; Taylor A; Verburg KM; Lefkowith JB; Whelton A
    Hypertension; 2002 Apr; 39(4):929-34. PubMed ID: 11967252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.
    Williams CS; Watson AJ; Sheng H; Helou R; Shao J; DuBois RN
    Cancer Res; 2000 Nov; 60(21):6045-51. PubMed ID: 11085526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of celecoxib and diclofenac on blood pressure, renal function, and vasoactive prostanoids in young and elderly subjects.
    Dilger K; Herrlinger C; Peters J; Seyberth HW; Schweer H; Klotz U
    J Clin Pharmacol; 2002 Sep; 42(9):985-94. PubMed ID: 12211224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
    Harris RE; Alshafie GA; Abou-Issa H; Seibert K
    Cancer Res; 2000 Apr; 60(8):2101-3. PubMed ID: 10786667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential involvement of cyclooxygenase isoforms in neutrophil migration in vivo and in vitro.
    Menezes GB; Rezende RM; Pereira-Silva PE; Klein A; Cara DC; Francischi JN
    Eur J Pharmacol; 2008 Nov; 598(1-3):118-22. PubMed ID: 18823975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal effects on a solitary kidney of specific inhibition of cyclooxygenease-2 after 24 h of complete ureteric obstruction in rats.
    Oztürk H; Ozdemir E; Otcu S; Büyükbayram H; Ihsan Dokucu A
    Urol Res; 2002 Sep; 30(4):223-6. PubMed ID: 12202939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
    Wang JL; Cheng HF; Shappell S; Harris RC
    Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F; Calabrese R; Stati T; del Basso P
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension.
    Widlansky ME; Price DT; Gokce N; Eberhardt RT; Duffy SJ; Holbrook M; Maxwell C; Palmisano J; Keaney JF; Morrow JD; Vita JA
    Hypertension; 2003 Sep; 42(3):310-5. PubMed ID: 12874094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting.
    Davis TW; Zweifel BS; O'Neal JM; Heuvelman DM; Abegg AL; Hendrich TO; Masferrer JL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):929-34. PubMed ID: 14711936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit.
    Rossoni G; Muscara MN; Cirino G; Wallace JL
    Br J Pharmacol; 2002 Mar; 135(6):1540-6. PubMed ID: 11906968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension.
    Boshra V; El Wakeel GA; Nader MA
    Can J Physiol Pharmacol; 2011 Feb; 89(2):103-7. PubMed ID: 21326341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G
    N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
    Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
    Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.